Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-6 of 6 for your search:
Drug:
dexrazoxane hydrochloride
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Pegasparaginase Verus E. coli Asparaginase With Combination Chemotherapy in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
1 to 17
Sponsor:
NCI
Protocol IDs:
DFCI-05001
, NCT00400946
2.
Phase II Pilot Study of Irinotecan and Carboplatin as Upfront Window Therapy in Patients With Newly Diagnosed Intermediate- or High-Risk Rhabdomyosarcoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
30 and under at diagnosis
Sponsor:
NCI
Protocol IDs:
MSKCC-03099
, NCT00077285
3.
Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Supportive care, Treatment
Status:
Active
Age:
18 to 70
Sponsor:
Other
Protocol IDs:
MBC0901 FUCH
, NCT00955890
4.
Phase I Study of Obatoclax Mesylate in Combination With Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Pediatric Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
6 months to 21 years
Sponsor:
NCI
Protocol IDs:
COG-ADVL0816
, ADVL0816, NCT00933985
5.
Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
5 to 40
Sponsor:
Other
Protocol IDs:
2007-0404
, NCT00673179
6.
Pilot Study of Zoledronic Acid in Combination With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Osteosarcoma
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
40 and under
Sponsor:
NCI
Protocol IDs:
COG-AOST06P1
, AOST06P1, NCT00742924
Select All on Page
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
